Jacksonville, FL (PRWEB) August 06, 2013
U.S. Preventive Medicine (USPM) has named Robert J. Tazioli as Chief Executive Officer effective August 1, 2013. The appointment signals a renewed focus by the accredited global health management firm on engaging consumers in recognizing and improving their health status.
Mr. Tazioli brings to his new role 28 years of senior management experience with progressive health care organizations. He has directed substantial revenue and earnings growth for health care services, business process outsourcing, managed care, disease/population health management, and software as a service (SAAS) entities.
Mr. Tazioli said, “I look forward to working with USPM’s dedicated team of professionals to execute on our mission of improving the quality of life for millions of people. We are committed to helping individuals live longer, healthier, and happy lives, while at the same time reducing their out-of-pocket expenses.”
“The Board of Directors unanimously agreed that Rob’s impressive track record in the health management movement gives him just the right qualifications to lead our company,” said David Gee, Chairman of the Board of Directors of USPM.
About Rob Tazioli
As EVP & Chief Development Officer for Connextions, Inc., Rob was a founding executive team member that grew annual revenue to $135 million in 7 years resulting in a highly successful exit when it was sold to UnitedHealth Group for $325 million. He was responsible for building Connextions’ direct-to-consumer strategy that served as the basis for its explosive growth.
Previously, he ran business development for Matria Healthcare (now Alere), one of the largest disease management/population health management companies, which was successfully sold to Inverness Medical. He was the Chief Development Officer for Implantable Provider Group, a leading device benefit management company. He also over
Copyright©2012 Vocus, Inc.
All rights reserved